NOXA1 antibody (C-Term)
Quick Overview for NOXA1 antibody (C-Term) (ABIN953741)
Target
See all NOXA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 454-483, C-Term
-
Specificity
- This antibody recognizes human NOXA1 at C-term.
-
Purification
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogen
- Synthetic peptide - KLH conjugated - corresponding to from the C-terminal region ( between 454-483aa) of human NOXA1
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- NOXA1 (NADPH Oxidase Activator 1 (NOXA1))
-
Alternative Name
- NOXA1
-
Background
- NADPH oxidases (NOXs) catalyze the transfer of electrons from NADPH to molecular oxygen to generate reactive oxygen species (ROS). The NOX activator NOXA1 can stimulate both NOX1 and NOX2, but it appears to be more effective in activating NOX1 [Opitz et al., 2007, PubMed 17189823].Synonyms: Antigen NY-CO-31, NADPH oxidase activator, NCF2-like protein, P51NOX, P67phox-like factor, p51-nox
-
Molecular Weight
- 50933 Da
-
Gene ID
- 10811
-
NCBI Accession
- NP_006638
Target
-